Stockreport

Biogen Reports New Data from Phase 1b Study of Investigational Alzheimer’s Disease Treatment Aducanumab

Biogen Inc.  (BIIB) 
Last biogen inc. earnings: 4/22 07:12 am Check Earnings Report
US:NASDAQ Investor Relations: biogen.com/en_us/investors.html
PDF Results Support Design of Ongoing Phase 3 Studies of Aducanumab for Early Alzheimer’s Disease CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Biogen (NASD [Read more]